Prostate cancer vaccine gets FDA approval
The U.S. Food and Drug Administration approved Provenge, a novel technique for fighting prostate cancer, on Thursday. The treatment involves taking a patient’s own white blood cells and using a drug that trains them to more actively attack cancer cells.
The treatment is intended only for men with so-called “metastatic castration-resistant” prostate cancer, for whom [...]
